{"entity":{"id":"embl-ebi","kind":"institution","name":"EMBL's European Bioinformatics Institute","aka":["EMBL-EBI","European Bioinformatics Institute","European Molecular Biology Laboratory"],"tldr":"Europe's public data institute for molecular biology, running Ensembl, ChEMBL, Europe PMC, the European Genome-phenome Archive and Open Targets.","summary":"EMBL-EBI is the bioinformatics site of the European Molecular Biology Laboratory (founded 1974; the EBI opened in Hinxton in 1994). It maintains open resources that cancer research runs on: Ensembl genome annotation, UniProt (with SIB and PIR), ChEMBL drug and bioactivity data, the PDBe structure archive, Expression Atlas, Europe PMC literature, the European Genome-phenome Archive for controlled-access patient genomes, and the AlphaFold Protein Structure Database built with Google DeepMind. It is a founding partner of Open Targets with the Sanger Institute and pharmaceutical companies, and trains thousands of scientists a year. EMBL's Heidelberg and other sites contribute structural, cell and imaging biology.","asOf":"2026-09-09","wikipedia":"https://en.wikipedia.org/wiki/European_Bioinformatics_Institute","links":[{"label":"Homepage","url":"https://www.ebi.ac.uk"},{"label":"Open Targets","url":"https://www.opentargets.org"},{"label":"Europe PMC","url":"https://europepmc.org"}],"tags":[],"related":["drugbank-chembl","open-targets","pubmed-europepmc","isomorphic-labs"],"cancers":[],"sections":["ai-computation","drug-discovery"],"technologies":["ai-drug-design","proteomics","wes-wgs","rna-seq"],"targets":[],"drugs":[],"companies":[],"institutions":["wellcome-sanger"],"pathways":[],"terms":[],"trials":[],"people":["ewan-birney","julio-saez-rodriguez"],"bottlenecks":["b-data-silos","b-knowledge-diffusion"],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"city":"Hinxton","country":"GB","lat":52.08,"lng":0.186,"institutionType":"research-institute","website":"https://www.ebi.ac.uk","programs":["Ensembl","ChEMBL","Europe PMC","European Genome-phenome Archive","Open Targets","AlphaFold DB"]},"route":"/institutions/embl-ebi/","neighbours":{"collection":[{"id":"drugbank-chembl","kind":"collection","name":"DrugBank & ChEMBL","route":"/collections/drugbank-chembl/"},{"id":"open-targets","kind":"collection","name":"Open Targets Platform","route":"/collections/open-targets/"},{"id":"pubmed-europepmc","kind":"collection","name":"PubMed & Europe PMC","route":"/collections/pubmed-europepmc/"}],"company":[{"id":"isomorphic-labs","kind":"company","name":"Isomorphic Labs","route":"/companies/isomorphic-labs/"}],"section":[{"id":"ai-computation","kind":"section","name":"AI & Computation","route":"/fronts/ai-computation/"},{"id":"drug-discovery","kind":"section","name":"Drug Discovery Platforms","route":"/fronts/drug-discovery/"}],"technology":[{"id":"ai-drug-design","kind":"technology","name":"AI-driven drug & target discovery","route":"/technologies/ai-drug-design/"},{"id":"proteomics","kind":"technology","name":"Proteomics & phosphoproteomics","route":"/technologies/proteomics/"},{"id":"rna-seq","kind":"technology","name":"RNA sequencing & expression profiling","route":"/technologies/rna-seq/"},{"id":"wes-wgs","kind":"technology","name":"Whole-exome & whole-genome sequencing","route":"/technologies/wes-wgs/"}],"institution":[{"id":"wellcome-sanger","kind":"institution","name":"Wellcome Sanger Institute","route":"/institutions/wellcome-sanger/"}],"person":[{"id":"ewan-birney","kind":"person","name":"Ewan Birney","route":"/people/ewan-birney/"},{"id":"julio-saez-rodriguez","kind":"person","name":"Julio Saez-Rodriguez","route":"/people/julio-saez-rodriguez/"}],"bottleneck":[{"id":"b-data-silos","kind":"bottleneck","name":"Data silos","route":"/bottlenecks/b-data-silos/"},{"id":"b-knowledge-diffusion","kind":"bottleneck","name":"Knowledge reaches practice too slowly","route":"/bottlenecks/b-knowledge-diffusion/"}]}}